Skip to content

Advertisement

  • Poster presentation
  • Open Access

2D-SENSE in isotropic slow infusion contrast-enhanced whole-heart coronary magnetic resonance angiography at 3 T

  • 1,
  • 2,
  • 3,
  • 2,
  • 1 and
  • 2
Journal of Cardiovascular Magnetic Resonance201012 (Suppl 1) :P50

https://doi.org/10.1186/1532-429X-12-S1-P50

  • Published:

Keywords

  • Magnetic Resonance Angiography
  • Slow Infusion
  • Signal Readout
  • Coronary Magnetic Resonance Angiography
  • Isotropic Voxel Size

Introduction

Slow infusion of Gd-BOPTA has been demonstrated to be effective in improving blood-myocardium CNR in whole-heart coronary MRA at 3 T[1]. However, its SNR has still been reported inferior to SSFP at 1.5 T[2]. SENSE has been previously exploited to enhance the SNR[3, 4].

Purpose

To evaluate the SNR & CNR performance of 2D-SENSE enhanced whole-heart coronary MRA post contrast in comparison to a conventional T2Prep approach in patients.

Methods

Eleven patients with established cardiovascular disease were studied on a commercial 3 T Philips system with a 32-channel cardiac surface coil.

Baseline free-breathing 3D whole-heart coronary MRA with an adiabatic T2prep (TE = 50 ms)[5] was first performed. The duration of the acquisition window was adjusted to the heart-rate of the patients with a TR/TE = 3.3/1.07 ms and a flip angle(α) of 20°. 1D-SENSE (2 times accelerated) was applied in the left-right(LR) direction. The acquired isotropic voxel size was 1.3 × 1.3 × 1.3 mm3.

Subsequently, 0.2 mmol/kg dose of Gd-BOPTA was injected at 0.3 cc/sec, and inversion-recovery (TI = 200 ms) whole-heart 2D-SENSE contrast-enhanced (CE)-MRA started 2 min after injection. Spatial/temporal resolution as well as volumetric coverage/scanning time remained unchanged relative to the baseline scan. However, post-contrast, a SENSE acceleration factor of 2 × 2 was used in the FH and LR directions. Rather than using 2D-SENSE to abbreviate scanning time, it was exploited to maximize SNR post-contrast by minimizing the signal readout bandwidth (TR/TE = 6.6/1.71 ms) and by optimizing α(= 25°). Based on a numerical simulation, the 2D-SENSE CE-MRA should improve SNR more than 2-fold vs. baseline.

Both scans were combined with a 3D noise scan (30 sec duration) to support SNR and CNR quantification on images acquired with SENSE. SNR, CNR, vessel length and sharpness were quantified and compared for the pre- and post-contrast acquisitions.

Results

The quantitative results are shown in Tables 1 &2. 2D-SENSE CE-MRA resulted in a 3-fold/7-fold increase in SNR/CNR vs. baseline. However, this did not translate into improved vessel sharpness or longer visible vessel length. Representative images from a patient are shown in Figure 1. Figure 2 shows 2D-SENSE CE-MRA and the corresponding X-ray coronary angiogram from a patient with RCA disease.
Table 1

SNR, CNR and scan duration for nonenhanced and 2D-SENSE CE-MRA.

Parameter

Non enhanced whole-heart MRA (T2prep)

Whole-heart CE-MRA (Gd-BOPTA, 2D-SENSE)

SNR (blood)

37.5 ± 14.7

121.3 ± 44.0*

CNR (blood-myocardium)

14.4 ± 6.9

101.5 ± 40.8*

Scan duration (min)

9.7 ± 3.6

12.3 ± 7.7

Navigator efficiency (%)

52.3 ± 13.0

47.9 ± 10.7

*Sigificance: p < 0.05 vs. T2prep values (paired two-sided Student t-test)

Table 2

Vessel length and vessel sharpness for nonenhanced and 2D-SENSE CE-MRA.

Parameter

Non enhanced whole-heart MRA (T2prep)

Whole-heart CE-MRA (Gd-BOPTA, 2D-SENSE)

Vessel length (cm)

LM + LAD

6.8 ± 2.1

7.5 ± 2.3

 

LCx

3.4 ± 0.8

3.9 ± 1.1

 

RCA

11.8 ± 3.1

10.6 ± 3.7*

Vessel sharpness (%)

LM + LAD

50.2 ± 6.6

46.7 ± 6.0

 

LCx

51.1 ± 8.7

42.7 ± 7.5*

 

RCA

51.5 ± 7.4

52.0 ± 11.1

*Sigificance: p < 0.05 vs. T2prep values (paired two-sided Student t-test)

LM = left main artery, LAD = left anterior descending artery, LCx = left circumflex, RCA = right coronary artery.

Figure 1
Figure 1

Multiplanar reformatted nonenhanced baseline (a and c) and 2D-SENSE CE-MRA (b and d) from a patient with myocarditis and a left ventricular ejection fraction of 20%.

Figure 2
Figure 2

Comparison of multiplanar reformatted 2D-SENSE CE-MRA image (a) and the corresponding X-ray angiogram (b) from a patient with RCA disease. Three locations of stenoses are indicated with solid, dashed and dotted arrows. The locations of the luminal narrowing in the proximal and mid RCA on the 2D-SENSE CE-MRA agree well with those seen on the x-ray angiogram.

Conclusion

Slow-infusion in combination with 2D-SENSE could be successfully exploited to substantially improve SNR and CNR in isotropic whole-heart coronary MRA at 3 T. Further methodological advances will help translate the considerable SNR and CNR advantage into an improved visible vessel length, vessel conspicuity and spatial resolution. This will be critical for larger patient studies that include a direct comparison with the x-ray coronary angiography.

Authors’ Affiliations

(1)
Johns Hopkins Medical Institutions, Baltimore, MD, USA
(2)
Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, Germany
(3)
Philips Healthcare, Hamburg, Germany

References

  1. Bi X et al: Whole - heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent. Magn Reson Med. 2007, 58 (1): 1-7. 10.1002/mrm.21224.View ArticlePubMedGoogle Scholar
  2. Liu X et al: Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T. Invest Radiol. 2008, 43 (9): 663-668. 10.1097/RLI.0b013e31817ed1ff.View ArticlePubMedGoogle Scholar
  3. Weiger M et al: Sensitivity encoding as a means of enhancing the SNR efficiency in steady-state MRI. Magn Reson Med. 2005, 53 (1): 177-185. 10.1002/mrm.20322.View ArticlePubMedGoogle Scholar
  4. Yu J et al: Improved SNR efficiency in gradient echo coronary MRA with high temporal resolution using parallel imaging. Magn Reson Med.Google Scholar
  5. Nezafat R et al: B1-insensitive T2 preparation for improved coronary magnetic resonance angiography at 3 T. Magn Reson Med. 2006, 55 (4): 858-864. 10.1002/mrm.20835.View ArticlePubMedGoogle Scholar

Copyright

© Yu et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.

Advertisement